Search - tctmd.com

Displaying 261 - 280 of 606

Sort: Relevancy | Date

Presentation TCT 2017

TAVR in Small Body-Sized Patients: Insight From the OCEAN-TAVI Japanese Multicenter Registry

Presenter: Samir R. Kapadia, Shigeru Saito, Yusuke Watanabe

October 29, 2017

Presentation TCT 2017

Initial Experience With Percutaneous Mitral Valve Repair in Japan

Presenter: Samir R. Kapadia, Shigeru Saito, Takashi Matsumoto

October 29, 2017

Presentation TCT 2017

Expanding TAVR Indications (Heart Failure, Asymptomatic Severe AS, and Aortic Regurgitation)

Presenter: Jeroen J. Bax, Axel Linke, Nicolas M. Van Mieghem

October 29, 2017

Presentation TCT 2017

TAVR in Low-Risk Patients

Presenter: Jeroen J. Bax, Axel Linke, Thomas Pilgrim

October 29, 2017

Presentation TCT 2017

Valve Thrombosis and Durability

Presenter: Jeroen J. Bax, Axel Linke, Lars Sondergaard

October 29, 2017

Presentation TCT 2017

TAVR vs SAVR: What Do the 2017 ESC Guidelines Say?

Presenter: Jeroen J. Bax, Axel Linke, Alec S. Vahanian

October 29, 2017

Presentation TCT 2017

How to Interpret Hemodynamic, CT, and Echo Data for TAVR Clinical Decision-making and Procedural Guidance

Presenter: Thomas H. Maloney, Paul D. Mahoney

October 29, 2017

News Opinion Fellow Talk

My Picks for Fellows Attending TCT 2017

Amit K. Gupta, MBBS, MD

October 26, 2017

News Daily News

Long-term Evidence Supports Better Survival for Women Than Men After TAVR

L.A. McKeown

October 23, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

Caitlin E. Cox

October 18, 2017

News Opinion Fellow Talk

Why All Interventionalists Should Be on Twitter

Amit K. Gupta, MBBS, MD

October 18, 2017

Presentation

Comparative Outcomes of US Patients With Advanced Renal Dysfunction Undergoing TAVR

October 17, 2017

Presentation

Death and Dialysis After TAVR:Analysis of STS/ACC TVT Registry

October 17, 2017

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

News Opinion Fellow Talk

Be a HOT Interventionalist With Honest, Open, Two-Way Communication

Kimberly Atianzar, MD

October 11, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

News Daily News

Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues

Caitlin E. Cox

October 06, 2017

Presentation

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Presenter: John D. Carroll,

October 06, 2017

Presentation CDM 2017

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Presenter: John D. Carroll

October 06, 2017

Advertisement

TAVR in Small Body-Sized Patients: Insight From the OCEAN-TAVI Japanese Multicenter Registry

Initial Experience With Percutaneous Mitral Valve Repair in Japan

Expanding TAVR Indications (Heart Failure, Asymptomatic Severe AS, and Aortic Regurgitation)

TAVR in Low-Risk Patients

Valve Thrombosis and Durability

TAVR vs SAVR: What Do the 2017 ESC Guidelines Say?

How to Interpret Hemodynamic, CT, and Echo Data for TAVR Clinical Decision-making and Procedural Guidance

My Picks for Fellows Attending TCT 2017

Long-term Evidence Supports Better Survival for Women Than Men After TAVR

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

Why All Interventionalists Should Be on Twitter

Comparative Outcomes of US Patients With Advanced Renal Dysfunction Undergoing TAVR

Death and Dialysis After TAVR:Analysis of STS/ACC TVT Registry

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Be a HOT Interventionalist With Honest, Open, Two-Way Communication

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content